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Abstract
Fibromyalgia syndrome (FMS) is a rheumatologic disorder characterized by chronic wide-
spread pain, fatigue and other symptoms. Baroreflex dysfunction has been observed in
women with FMS. However, it is unknown whether the limited involvement of the baroreflex
control during an orthostatic stimulus has some impact on the quality of life of the FMS
patient. Therefore, the aim of the study is evaluate the relationship between the quality of life
of the FMS patient and indexes of the cardiovascular autonomic control as estimated from
spontaneous fluctuations of heart period (HP) and systolic arterial pressure (SAP). We
enrolled 35 women with FMS (age: 48.8±8.9 years; body mass index: 29.3±4.3 Kg/m2). The
electrocardiogram, non-invasive finger blood pressure and respiratory activity were continu-
ously recorded during 15 minutes at rest in supine position (REST) and in orthostatic posi-
tion during active standing (STAND). Traditional cardiovascular autonomic control markers
were assessed along with a Granger causality index assessing the strength of the causal
relation from SAP to HP (CRSAP!HP) and measuring the degree of involvement of the car-
diac baroreflex. The impact of FMS on quality of life was quantified by the fibromyalgia
impact questionnaire (FIQ) and visual analog score for pain (VAS pain). No significant linear
association was found between FIQ scores and the traditional cardiovascular indexes both
at REST and during STAND (p>0.05). However, a negative relationship between CRSAP!HP
during STAND and FIQ score was found (r = -0.56, p<0.01). Similar results were found with
VAS pain. In conclusion, the lower the degree of cardiac baroreflex involvement during
STAND in women with FMS, the higher the impact of FMS on the quality of life, thus sug-
gesting that Granger causality analysis might be clinically helpful in assessing the state of
the FMS patient.
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Introduction
Fibromyalgia syndrome (FMS) is a rheumatologic disorder characterized by chronic wide-
spread pain, fatigue and other symptoms that might be related to dysautonomia (i.e., insom-
nia, irritable bowel, anxiety, depression) [1]. As a consequence, autonomic function and
cardiovascular control have been frequently assessed in FMS and their evaluation has been
typically based on the analysis of spontaneous fluctuations of heart period (HP) and systolic
arterial pressure (SAP) [2–6]. These studies have reported that patients with FMS feature an
increased sympathetic control and a reduced vagal modulation in supine position at rest
(REST) [4,7,8], a lower cardiac baroreflex sensitivity compared to age-matched healthy
subjects at REST [4,7,8], an inability of reducing further baroreflex sensitivity during an or-
thostatic challenge such as active standing (STAND) [6] and a limited involvement of the bar-
oreflex control in regulating arterial blood pressure during STAND as detected by Granger
causality analysis [6]. However, whether all these parameters derived from HP and SAP vari-
abilities are related to the quality of life of the FMS patient, as assessed from a clinical score
such as the fibromyalgia impact questionnaire (FIQ) and the visual analog score for pain (VAS
pain), is unknown.
We hypothesize that FMS patients with higher FIQ and VAS pain scores, indicating a poor
quality of life, are those with lower degree of cardiac baroreflex involvement during STAND as
a manifestation of their inability to deal with this common task in their daily life.
Therefore, the present study aims to evaluate the relationship between the quality of life of
FMS women and indexes of the cardiovascular autonomic control estimated from spontane-
ous HP and SAP variabilities. This analysis is not only limited to traditional markers derived
from HP and SAP variabilities but it includes even those quantifying the strength of the causal
relation along a given time direction (e.g. from SAP to HP along cardiac baroreflex) computed
according to Granger causality analysis.
Materials and methods
The study was approved by the Ethics in Research Committee from Federal University of Sao
Carlos (protocol number 112.508). All participants gave written informed consent.
Enrolled population
From January 2013 to December 2015, 35 women with clinical diagnosis of FMS took part in
the study (age: 48.8±8.9 years; body mass index: 29.3±4.3 Kgm-2). The diagnosis was made by
a board certified rheumatologist according to criteria established by the American College
of Rheumatology [9]. The subjects were recruited from local community among those who
responded to flyers posted in university buildings, orthopedic and rheumatologic clinics, or
belonged to our database of FMS patients. The enrolled subjects had no history of cardiovascu-
lar, respiratory or metabolic disease, inflammation, neurological disorders and cognitive defi-
cits preventing the regular progress of the study. They were not smokers, or engaged in regular
physical activity, or make continuous use of drugs or alcohol.
Experimental procedure
All experiments were carried out in the morning (8 a.m. to 12 p.m.) to minimize the impact of
the circadian rhythm on cardiovascular variables. Room temperature was maintained at 22˚C
and the relative air humidity between 40% and 60%. Participants were acquainted with the
experimental protocol and were instructed to abstain from stimulants (coffee, tea, soft drinks)
and alcoholic beverages for the 24 hours preceding the examination, and to have a light meal
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at least two hours before the test. Subjects were asked to avoid strenuous physical activity in
the two days before the tests. Participants took no psychotropic drugs or other medications
known to alter autonomic activity for at least 4 weeks before the study, including beta-block-
ers, antihypertensive drugs, tranquilizers, or antidepressants. The participants with regular
menstrual cycle (28 ± 2 days) were assessed during the follicular phase, i.e., 7–10 days after the
start of menses.
We recorded surface ECG (modified lead I) (BioAmp FE132, ADInstruments, Australia),
noninvasive blood pressure (Finometer Pro, Finapres Medical Systems Ohmeda, Amsterdam,
Netherland), and respiratory activity via a piezoelectric respiratory belt (Thoracic Belt, Mar-
azza, Monza, Italy) from every subject. The arterial pressure signal was cross-calibrated in each
session by measuring the blood pressure with a sphygmomanometer at the onset of the session.
Signals were sampled at 1000 Hz using a commercial device (BioAmp Power Lab, AD Instru-
ments, Australia).
Data acquisition was performed for 15 minutes at REST and during STAND. Before begin-
ning data acquisition, about 20 minutes were allowed for hemodynamic stabilization.
Extraction of the beat-to-beat variability series
Standard procedures were followed to build the beat-to-beat HP and SAP variability series [6].
Briefly, HP was measured from the ECG as the temporal distance between two consecutive R-
wave peaks. The maximum arterial pressure value was identified in the HP and taken as SAP.
Respiratory (RESP) series was obtained by sampling the respiratory signal at the R-wave peak.
Series lengths of 256 consecutive measures were extracted from the entire HP, SAP and RESP
sequences both at REST and during STAND. Stationarity of the HP and SAP series was
checked according to the test proposed in [10].
Power spectral density estimation
Power spectrum was estimated according to a parametric approach fitting the series with an
autoregressive (AR) model [11]. AR spectral technique provided a factorization of the spectral
density into components that were classified according to their central frequency. If the central
frequency belonged to the low frequency (LF, from 0.04 to 0.15 Hz) band or to the high fre-
quency (HF, from 0.15 to 0.5 Hz) band, the corresponding component was labeled as LF or
HF respectively. The LF, or HF, power was computed as the sum of the powers of all LF, or
HF, components.
Frequency domain assessment of cardiac baroreflex sensitivity
The cardiac baroreflex sensitivity was computed as the square root of the ratio of the power of
HP to that of SAP. The ratio was calculated in both LF and HF bands [11] and indicated as
αHF and αLF respectively. Two parameters were considered as prerequisites for the reliable esti-
mation of cardiac baroreflex sensitivity [11]: i) the squared coherence function K2HP-SAP
should be higher than 0.5 at the considered central frequency as an indication of a significant
HP-SAP correlation; ii) the phase of the cross-spectrum PhHP-SAP should be lower than 0 at
the considered central frequency as an indication that HP changes lag behind SAP variations
[11].
Granger causality evaluation
A Granger causality approach [12–14] was utilized to assess the strength of the directed depen-
dence of HP on SAP via the computation of the causality ratio (CR) (CRSAP!HP). This index
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was computed over the set of variability series O = {HP,SAP,RESP}. SAP is said to Granger-
cause HP if the HP dynamics can be better predicted in O than in O after exclusion of the pre-
sumed cause SAP (i.e., O\SAP = {HP,SAP}) [15]. The inclusion of RESP in O assures that the
RESP influences are disambiguated while assessing the directionality of the HP-SAP variability
interactions [16,17]. Granger approach to the evaluation of causality from SAP to HP was
described in detail elsewhere [12,13]. Briefly, after defining the prediction error as the differ-
ence between the current HP value and its prediction based on a linear regression model,
CRSAP!HP is computed as the fractional predictability improvement of HP due to the intro-
duction of SAP in O\SAP. Thus, the higher and positive the CRSAP!HP is, the stronger the
strength of the causal link from SAP to HP. The significance of CRSAP!HP was checked by
comparing the mean square prediction error of HP in O and in O\SAP via the F-test [18]. If
the CRSAP!HP adjusted for the degrees of freedom [17,18] was larger than the critical value
of the F distribution for a significance level of 0.01, the null hypothesis of absence of a causal
relation from SAP to HP was rejected and we accepted the alternative hypothesis that SAP
Granger-caused HP, indicated as SAP!HP in the following. SAP!HP is taken as an indica-
tion that cardiac baroreflex is working and CRSAP!HP measured its degree of involvement.
Quality of life and pain assessment
The quality of life was assessed by the FIQ. This questionnaire was specifically developed to
assess disease severity and impact of FMS on the subject’s quality of life. This questionnaire
comprises issues related to functional ability, professional situation, psychological disorders
and physical symptoms. The score of this questionnaire ranges from 0 to 100, and the higher
the score, the greater the impact of FMS on the subject’s quality of life [19]. It was shown that
the FIQ score was able to capture the overall effect of FMS and measure the individual
response to the application of a clinical protocol [20,21].
A 100-mm visual analogue scale (VAS) was applied to evaluate the current intensity of over-
all body pain felt at rest (0 = no pain, 100 = worst pain ever felt).
Statistical analysis
Gaussianity of the data was verified by Shapiro-Wilk test. Linear regression analysis was used
to assess the association between the impact of FMS on quality of life, assessed by the FIQ, and
the indexes of the cardiovascular autonomic control. Pearson’s correlation coefficient r was
computed and type I error probability p was estimated. Partial correlation analyses were car-
ried out between FIQ or VAS pain and the indexes of the cardiovascular autonomic control-
ling for body mass index (BMI) and disease duration. Statistical significance was set at 5% for
all tests. SPSS 20.0 (SPSS, Inc, Chicago, IL) was used for all analysis.
Results
Table 1 displays the demographic characteristics of our FMS group in resting condition. As
expected, FMS patients featured pain as evident from the elevated VAS pain score and the high
number of tender points. In our group BMI was larger than 25 kg/cm2 in 91.4% of the
subjects.
Results of the correlation analysis between the cardiovascular control markers derived from
HP and SAP variability series and the FIQ score are shown in Table 2. Traditional autonomic
indexes in time and frequency domains were not significantly associated with the FIQ score
both at REST and during STAND (p>0.05). CRSAP!HP was unrelated to FIQ score at REST
(Fig 1A). However, a significant and negative relation of CRSAP!HP on FIQ score was found
during STAND (r = -0.56, p<0.01, Fig 1B). A similar result was found between a marker of
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pain intensity in resting condition (i.e. VAS pain) and CRSAP!HP (r = -0.38 with p<0.05 only
during STAND). Results were confirmed even when correlation analyses were carried out by
accounting for BMI (CRSAP!HP and FIQ: r = -0.55, p<0.001; CRSAP!HP and VAS pain: r =
-0.38, p<0.03) and disease duration (CRSAP!HP and FIQ: r = -0.58, p<0.0001; CRSAP!HP and
VAS pain: r = -0.39, p<0.02).
Discussion
The main findings of the present study are that the FMS patients with lower degree of cardiac
baroreflex involvement during STAND (i.e. with Granger causality ratio from SAP to HP close
to zero) were those with higher impact of FMS on quality of life and with higher pain in resting
condition. These findings corroborate our hypothesis that lower degree of baroreflex involve-
ment during an orthostatic stressor could be negatively related to the quality of life. Remark-
ably, more traditional univariate and bivariate cardiovascular control indexes derived from
Table 1. Demographic characteristics of the FMS population in resting condition.
Variables FMS (n = 35)
Age (years) 48.83 ± 8.89
Weight (kg) 73.49 ± 12.34
Height (cm) 158.09 ± 5.78
BMI (kg/m2) 29.27 ± 4.31
HR (bpm) 72.09 ± 8.87
SAP (mmHg) 120.71 ± 12.14
DAP (mmHg) 74.29 ± 8.06
Respiratory rate (rpm) 15.86 ± 2.50
VAS pain (0–100 mm) 49.2 ± 20.6
Number of tender points (0–18) 16.97 ± 1.89
Disease duration (years) 9.20 ± 6.29
BMI: body mass index; HR: heart rate; SAP: systolic arterial pressure; DAP: diastolic arterial pressure; VAS
pain: visual analog scale for pain.
https://doi.org/10.1371/journal.pone.0179500.t001
Table 2. Linear correlation analysis of the cardiovascular control parameters on the FIQ score at REST and during STAND.
Cardiovascular parameters REST STAND
r p r p
μHP -0.08 0.64 0.05 0.77
σ2HP -0.06 0.71 0.24 0.17
HFHP 0.07 0.69 0.34 0.04
μSAP -0.06 0.71 0.13 0.44
σ2SAP -0.004 0.98 0.17 0.32
LFSAP -0.09 0.61 0.06 0.73
αLF -0.10 0.58 -0.07 0.69
αHF -0.05 0.77 0.19 0.26
CRSAP!HP 0.10 0.57 -0.56 <0.01
HP: heart period; SAP: systolic arterial pressure; LF: low frequency; HF: high frequency; μHP: HP mean; σ2HP: HP variance; HFHP: HF power of HP series
expressed in absolute units; μSAP: SAP mean; σ2SAP: SAP variance; LFSAP: LF power of SAP series expressed in absolute units; αLF: baroreflex sensitivity
assessed in the LF band; αHF: baroreflex sensitivity assessed in the HF band; CRSAP!HP: Granger causality ratio from SAP to HP; r: Pearson’s correlation
coefficient; p: probability of type I error.
https://doi.org/10.1371/journal.pone.0179500.t002
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Fig 1. The scatter plots of CRSAP!HP on FIQ score are shown at REST (a) and during STAND (b). Each solid
circle is relevant to a pair (FIQ score, CRSAP!HP) computed over a single individual. The linear regression is shown
as well when a significant association between the two variables is found with p<0.05.
https://doi.org/10.1371/journal.pone.0179500.g001
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HP and SAP variability series were not significantly related to the quality of life of the FMS
patient.
To our knowledge, this is the first study assessing the association between a Granger causal-
ity index and a clinical measure of the quality of life, as assessed by the FIQ score, in the FMS
patient. The CRSAP!HP measures the strength of the causal link from SAP to HP, thus quanti-
fying the degree of involvement of the cardiac baroreflex [14]. It is known that an orthostatic
stimulus increases the involvement of cardiac baroreflex in governing HP changes [22,23]. A
possible explanation relies on the unloading of cardiopulmonary and arterial baroreceptors
consequent to the decrease of the central blood volume, leading to the activation of the cardiac
baroreflex in the attempt to prevent the arterial pressure drop. A recent study revealed that a
considerable amount of subjects with FMS featured an impaired baroreflex control during
STAND, as indicated by a reduced gain of the HP-SAP relation usually referred to as barore-
flex sensitivity [6]. However, while modifications of the cardiac baroreflex sensitivity in FMS
are well-known as well as changes of the cardiac baroreflex solicitation, as measured by the
strength of the causal relation from SAP to HP [6], it is unknown their relation with the sub-
ject’s quality of life.
Complaining about symptoms such as palpitations, fatigue and inability to cope with
STAND for prolonged times is common in patients with FMS [24]. Indeed, Furlan et al [4]
reported a reduced orthostatic tolerance in patients with FMS as stressed by the higher rates of
syncope in patients with FMS compared to a healthy control group. Moreover, Bou-Holaigah
et al. [25] reported an abnormal decrease of blood pressure during head-up tilt test in patients
with FMS leading to syncope or presyncope defined as a drop in SAP of at least 25 mmHg
with no associated increase in heart rate.
It is well known that orthostatic intolerance interferes with quality of life [26]. Although the
FIQ does not comprise any direct question related to orthostatic intolerance or presyncope
symptoms, it is likely that the difficulty in coping with this important stressor might signifi-
cantly impact the perception that a subject has about his/her health state and, consequently,
his/her quality of life. This perception might have an indirect impact on several answers of the
FIQ questionnaire leading to higher scores. The FIQ score is considered a clinical measure
of the quality of life in the FMS patient since it captures the overall effect of FMS and also the
individual response to a clinical protocol devised to improve the health state of the FMS
patient [20,21]. It is composed by 19 questions organized in 10 items measuring physical func-
tioning, daily living activities, work status, depression, anxiety, goodness of sleep, pain, stiff-
ness, fatigue, and well-being. The higher the score is, the higher the impact of FMS on quality
of life and the worse the condition of the FMS patient. Therefore, a reduced orthostatic toler-
ance due to the cardiac baroreflex dysfunction could interfere with the FMS patient’s ability to
deal with his/her daily life activities, thus supporting the possible association of cardiac barore-
flex parameters with the quality of life in FMS patients. As a matter of fact, we found that the
FIQ score was associated with the degree of baroreflex involvement in regulating HP-SAP
dynamical interactions as assessed from the strength of causal relation from SAP to HP, even
after controlling for BMI and disease duration. The lower (and the closer to zero) the strength
of the causal link from SAP to HP, the higher the FIQ score and, thus, the worse the impact of
FMS on the quality of life.
Another noteworthy result of this study is the negative association between the strength of
causal relation from SAP to HP during STAND and a measure of the pain intensity in resting
condition (i.e. VAS pain), which also remained after controlling for BMI and disease duration.
Thus, the FMS women with lower strength of the causal link from SAP to HP were those with
higher levels of pain in resting condition. A previous study has reported that baroreflex sensi-
tivity and sympathetic activity were significantly associated with pain intensity in women with
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FMS [27]. Several mechanisms have been proposed to explain this association, such as the
interactions between the autonomic and sensory systems occurring in the nucleus tractus soli-
tarius integrating information from baroreceptor inputs and neurons implicated in pain mod-
ulation [8,27–30]. Given that pain is directly captured by a component of the FIQ and the
possible association between pain and baroreflex impairment, the observed link between the
quality of life and the degree of baroreflex involvement might be the reflex of the association of
the quality of life with pain. However, the different degrees of association suggest that the rela-
tion between the quality of life and the baroreflex involvement might be not the mere conse-
quence of the increased cardiovascular deconditioning with the pain intensity.
Traditional cardiovascular control indexes were found to be unrelated to the FIQ score.
This finding stresses the clinical relevance to account for causality in studies assessing the car-
diovascular autonomic control. The relevance of accounting for causality in FMS patients was
already proved by Zamune´r et al. [6] who showed a diminished cardiac baroreflex gain at
REST using a model-based causal approach and a reduced involvement of cardiac baroreflex
control in regulating arterial blood pressure during STAND via a Granger causality assess-
ment. The present study confirms causality analysis conveys complementary information to
traditional cardiovascular control indexes given that the unique index exhibiting a significant
relation with FIQ score or pain intensity was CRSAP!HP. In addition, this study proves that
causality indexes are clinically relevant given their relation with the quality of life. Remarkably,
the association between the strength of the baroreflex involvement and the FIQ score was not
detected at REST, thus stressing the importance of challenging cardiovascular control to evoke
meaningful responses useful for clinical purposes.
Among the possible limitations of the study there are the limited sample size and the sole
inclusion of subjects after complete wash-out. Since increasing the sample size would augment
the power of the protocol, future studies should check whether the limited association between
traditional cardiovascular control indexes and the FIQ score is primarily the result of the small
sample size. Moreover, future protocols should enroll subjects under standard medication to
understand whether the use of drugs improves the degree of involvement of cardiac baroreflex
and this improvement could finally lead to a better quality of life.
Conclusions
The study suggests that the lower the degree of cardiac baroreflex involvement during STAND
in women with FMS, the higher the impact of FMS on the quality of life. This result stresses
the clinical relevance of computing directionality of the interactions along with cardiac barore-
flex from spontaneous fluctuations of SAP and HP to provide a quantitative assessment of the
state of the FMS patient.
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